Author:
Grabbi E.,Lucioni C.,Duran A.,Spaepen E.,Lamotte M.,Kutikova L.,Pujol B.,Gozzo M.,Iannazzo S.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy
Reference29 articles.
1. Cella D, Kallich J, McDermott A, et al. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol 2004; 15: 979–86
2. Kimel M, Leidy NK, Mannix S, et al. Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/ AIDS, and chronic kidney disease. Value Health 2008; 11: 57–75
3. Bokemeyer C, Aapro MS, Courdi A, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 2007; 43: 258–70
4. Danova M, Del Mastro L, Giordano M, et al. Linee Guida AIOM 2010 — Gestione della tossicità ematopoietica in oncologia. http://www.aiomit/UrlRewriting/RewritingEngineasp?RWdescrizione=Attivit%c3%a0+Scientifica/Linee+guida/Archivio+2010/Gestione+della+tossicit%c3%a0+ematopoietica+in+oncologia&RWid=4764&RWpage=0&RWType=1&RWURL=1 2011 December
5. Rizzo JD, Seidenfeld J, Piper M, et al. Erythropoietin: a paradigm for the development of practice guidelines. Hematology Am Soc Hematol Educ Program 2001; 10-30